From a standing ovation in the plenary hall for a pancreatic cancer breakthrough to a session on the coming wave of young cancer patients, here are five highlights that showcase the depth and reach of Moores Cancer Center at ASCO 2026.
Ludmil Alexandrov, PhD will address the Panel and present on Mutational Signatures for Identifying the Mutagenic Causes of Cancer. The Panel is a three-person federal advisory committee that delivers recommendations to the President on opportunities to reduce the national cancer burden.
Drug delivery and diagnostic imaging often lack specificity, but a new “TRACE” method lets specially‑caged compounds stay inert until a target cell’s enzymes quickly remove the cage, potentially allowing for more precise drug delivery and sharper diagnostic imaging.
UC San Diego researchers discovered that blocking microRNA-25 reshapes the tumor immune environment and improves responses to cancer immunotherapy.
A new AI model developed by UC San Diego researchers could make it possible to predict treatment response based only on a tumor's genetics.
The Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program at Drexel University College of Medicine has selected two University of California San Diego School of Medicine faculty to be part of its 32nd class of fellows.
Independent, March 10
The Hill, November 14
Keep up with all the latest from Moores Cancer Center. Subscribe to the newsletter today.
